MICRhoGAM Alternatives Compared
| MICRhoGAM (rho (d) immune globulin) | Nplate (romiplostim) | Promacta (eltrombopag) |
|
|---|
| MICRhoGAM (rho (d) immune globulin) | Nplate (romiplostim) | Promacta (eltrombopag) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Rh-Isoimmunization, Immune Thrombocytopenia. MICRhoGAM may also be used for purposes not listed in this medication guide. |
Prescription only
Nplate may be used to increase platelet counts above 50 x 109/L in adults and children with ITP who have not had a good response to corticosteroids, immunoglobulins, or removal of their... View more |
Prescription only
Promacta is an oral tablet or suspension that is taken daily to boost platelet numbers in people with chronic ITP, severe aplastic anemia, or chronic hepatitis C. Nausea, diarrhea, infections, and... View more |
Related suggestions Immune Thrombocytopenia
|
|||||||||||||||
| More about MICRhoGAM (rho (d) immune globulin) | More about Nplate (romiplostim) | More about Promacta (eltrombopag) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Nplate has an average rating of 7.5 out of 10 from a total of 11 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 9% reported a negative effect. |
Promacta has an average rating of 6.8 out of 10 from a total of 18 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all MICRhoGAM side effects |
View all Nplate side effects |
View all Promacta side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Nplate prices |
View all Promacta prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other rho (d) immune globulin brands include: Anti-D (RHO) Immunoglobulin, BayRHo-D, BayRHo-D Full Dose, BayRHo-D Mini-Dose, D-Gam Anti-D, Gamulin Rh, HyperRHO S/D Full Dose, HyperRHO S/D Mini-Dose, HypRho-D Mini-Dose, MicRhoGAM Ultra-Filtered Plus, RhoGAM Ultra-Filtered Plus, Rhophylac, WinRho SDF View more |
N/A |
Other eltrombopag brands include: Alvaiz, Promacta Kit | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
624 hours |
816 hours |
35 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 100 drugs are known to interact with MICRhoGAM:
|
A total of 9 drugs are known to interact with Nplate:
|
A total of 184 drugs are known to interact with Promacta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
August 22, 2008 |
November 20, 2008 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.